Schwegman is proud to sponsor the First-Time Attendee Networking Event at the AUTM 2019 Annual Meeting on Sunday, February 10 in Austin, TX. AUTM’s Annual Meeting invites technology transfer professionals from around the globe to network, make deals and gain valuable insights from world-class speakers and panels. This four-day meeting will be held on February 10-13 at […]
Schwegman is proud to sponsor the 2018 MABL Scholarship Gala. The Minnesota Association of Black Lawyers (MABL) is the leading minority bar association whose mission is to promote and support the professional development of Black lawyers, judges, and law students in Minnesota. This annual event will be held at the Marriot City Center in Minneapolis, […]
Principal attorney Doug Portnow is a contributing writer of the newly published American Bar Association book, “IP Strategies for Medical Device Technologies: Be Your Own Incubator.” This book is an essential resource for inventors, attorneys, IP professionals, or anyone with an interest in medical device IP for understanding the nuances of protecting and launching a […]
Mark Stignani will be joining an AIPLA panel discussion on IP Data Analytics, machine learning and artificial intelligence and how it can benefit IP Professionals. The webinar is on Wednesday, November 14 and you can register here. Along with Mark, the other panelists (from SAP, Cleveland Golf, ConvergentAI) have a wealth of information that they eagerly look forward to […]
Schwegman sponsored the Santa Clara University Diversity Gala on October 18, 2018. The Gala celebrates the accomplishments of individuals and organizations committed to promoting a diverse profession. This event took place in Santa Clara, CA at Charney Hall, Santa Clara University. Click here to learn more.
Are you looking for a brief overview of the October 4th Federal Circuit decision on Aqua Products, Inc. v. Matal? Check out this 10 minute video created by Tim Bianchi that shows the practical impact and questions raised by the Aqua Products decision.
David Kramer and Theo Nittis, of Oswald Companies will be at the Schwegman office to present on crucial risk management lessons that every attorney should know. As a former practicing attorney, David Kramer uses his legal background to assist law firms of all sizes with insurance placement, policy structuring, and risk management. Prior to entering the […]
This following is a recap of the Manhattan March for Science by Robin Chadwick. The March for Science in Manhattan was smaller than the January 2017 Women’s March in Washington, but large enough that the “entry point” for us was changed from 62nd Street to 64th and then to 68th Street as we moved up Broadway to get over […]
In my last post, I discussed estoppel in the context in inter partes review, in which defendant filed for IPR after losing in the courts. The Board found the claims-in-suit to be obvious. The Federal Circuit affirmed that the courts and the PTAB could reach different conclusions about patentability. In Fairchild (Appeal no. 17-1002 (Fed. Cir., […]
After Novartis’ patents were found nonobvious by the Fed. Cir., affirming the Delaware District Court, defendant Noven filed for inter partes review (IPR) of U.S. Pat. Nos. 6316023 and 6335031, on rivastigmine and an antioxidant. The PTAB found the asserted claims obvious and Novartis appealed to the Fed. Cir., that affirmed (Novartis AG, LTS v. […]